(1R,3S,5R)-3-(6-chloro-pyridin-3-yloxymethyl)-2-methyl-2-azabicyclo[3.1.0]hexane hydrochloride

ID: ALA4648968

PubChem CID: 156021795

Max Phase: Preclinical

Molecular Formula: C12H16Cl2N2O

Molecular Weight: 238.72

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1[C@H](COc2ccc(Cl)nc2)C[C@H]2C[C@H]21.Cl

Standard InChI:  InChI=1S/C12H15ClN2O.ClH/c1-15-9(4-8-5-11(8)15)7-16-10-2-3-12(13)14-6-10;/h2-3,6,8-9,11H,4-5,7H2,1H3;1H/t8-,9-,11+;/m0./s1

Standard InChI Key:  WIJZCDGQUPKLRA-WUKJGCQFSA-N

Molfile:  

     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
    3.5205   -1.6160    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5471    1.7877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3186    1.7916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1684    0.5505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8826    1.7887    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6006    1.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6247    2.0645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0658    1.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0372    1.3500    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2165    2.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8041    3.4891    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4011    2.6044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1687    1.3755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5455    0.1372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0409    2.7816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2618    1.3791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2632    0.5490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2305    0.6527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9716    0.1395    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 12 10  1  0
 10 11  1  1
  6  5  1  0
 17 14  1  0
  7  9  1  1
 10 15  1  0
  3 12  1  0
  7 10  1  0
  2 16  1  0
  4 13  1  0
  7  8  1  0
  7 15  1  0
  5 13  1  0
 13  2  2  0
  3  6  1  1
  4 14  2  0
  8  3  1  0
 16 17  2  0
  8 18  1  0
 17 19  1  0
M  END

Associated Targets(Human)

CHRNB2 Tclin Neuronal acetylcholine receptor; alpha4/beta2 (3972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 238.72Molecular Weight (Monoisotopic): 238.0873AlogP: 2.21#Rotatable Bonds: 3
Polar Surface Area: 25.36Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.42CX LogP: 1.86CX LogD: 0.80
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.76Np Likeness Score: -0.67

References

1. Nirogi R, Mohammed AR, Shinde AK, Ravella SR, Bogaraju N, Subramanian R, Mekala VR, Palacharla RC, Muddana N, Thentu JB, Bhyrapuneni G, Abraham R, Jasti V..  (2020)  Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression.,  63  (6): [PMID:32026697] [10.1021/acs.jmedchem.9b00790]

Source